| Literature DB >> 31491388 |
Deniz Demircioğlu1, Engin Cukuroglu2, Martin Kindermans2, Tannistha Nandi2, Claudia Calabrese3, Nuno A Fonseca4, André Kahles5, Kjong-Van Lehmann6, Oliver Stegle7, Alvis Brazma8, Angela N Brooks9, Gunnar Rätsch10, Patrick Tan11, Jonathan Göke12.
Abstract
Most human protein-coding genes are regulated by multiple, distinct promoters, suggesting that the choice of promoter is as important as its level of transcriptional activity. However, while a global change in transcription is recognized as a defining feature of cancer, the contribution of alternative promoters still remains largely unexplored. Here, we infer active promoters using RNA-seq data from 18,468 cancer and normal samples, demonstrating that alternative promoters are a major contributor to context-specific regulation of transcription. We find that promoters are deregulated across tissues, cancer types, and patients, affecting known cancer genes and novel candidates. For genes with independently regulated promoters, we demonstrate that promoter activity provides a more accurate predictor of patient survival than gene expression. Our study suggests that a dynamic landscape of active promoters shapes the cancer transcriptome, opening new diagnostic avenues and opportunities to further explore the interplay of regulatory mechanisms with transcriptional aberrations in cancer.Entities:
Keywords: RNA sequencing; TCGA; alternative promoters; cancer; computational biology; gene expression; genomics; survival analysis; transcriptional regulation; transcriptomics
Mesh:
Year: 2019 PMID: 31491388 DOI: 10.1016/j.cell.2019.08.018
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582